MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

PUB

102.75

+0.69%↑

SAB2

2.521

+0.64%↑

MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

PUB

102.75

+0.69%↑

SAB2

2.521

+0.64%↑

MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

PUB

102.75

+0.69%↑

SAB2

2.521

+0.64%↑

MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

PUB

102.75

+0.69%↑

SAB2

2.521

+0.64%↑

MC

701.9

+0.8%↑

SAF

244

-1.69%↓

MUV2

513.6

-0.35%↓

PUB

102.75

+0.69%↑

SAB2

2.521

+0.64%↑

Search

Gimv NV

Closed

Sector Finance

36.8 0.14

Overview

Share price change

24h

Current

Min

36.8

Max

36.85

Key metrics

By Trading Economics

Income

59M

Sales

89M

P/E

Sector Avg

5.251

26.698

Dividend yield

6.89

Profit margin

66.486

Employees

93

EBITDA

59M

Dividends

By Dow Jones

Dividend yield

Sector Avg

6.89%

3.82%

Next Earnings

22 May 2025

Market Stats

By TradingEconomics

Market Cap

1.3B

Previous open

36.66

Previous close

36.8

News Sentiment

By Acuity

50%

50%

224 / 545 Finance

Gimv NV Chart

Past performance is not a reliable indicator of future results.

Related News

22 Feb 2025, 00:16 UTC

Hot Stocks

Stocks to Watch: Alamos Gold, Booking Holdings

22 Feb 2025, 16:33 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 15:15 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 14:32 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 13:49 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 13:22 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

21 Feb 2025, 23:22 UTC

Top News

DOGE Aide's IRS Access Won't Include Personal Information -- Update

21 Feb 2025, 23:20 UTC

Earnings

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

21 Feb 2025, 22:34 UTC

Market Talk

L'Oréal Cuts Exposure to Chinese Market, Grows Emerging Markets -- Market Talk

21 Feb 2025, 22:12 UTC

Top News

DOJ Investigates Medicare Billing Practices at UnitedHealth -- 2nd Update

21 Feb 2025, 21:54 UTC

Top News

Why Is Warren Buffett Hoarding So Much Cash? -- 2nd Update

21 Feb 2025, 21:51 UTC

Earnings

Tesla Stock Falls. Recalls and Rivian Are in the News. -- Barrons.com

21 Feb 2025, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

21 Feb 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 Feb 2025, 21:50 UTC

Top News

DOGE Aide's IRS Access Won't Include Personal Information -- WSJ

21 Feb 2025, 21:48 UTC

Market Talk
Earnings

L'Oréal Tops Estée Lauder in Luxury U.S. Market, CEO Says -- Market Talk

21 Feb 2025, 21:35 UTC

Market Talk

Bulk of U.S. Imports From Canada Used to Make U.S. Goods -- Market Talk

21 Feb 2025, 21:28 UTC

Top News

Why Is Warren Buffett Hoarding So Much Cash? -- Update

21 Feb 2025, 21:24 UTC

Top News

Major U.S. Stock Indexes Give Up Gains From the Week -- WSJ

21 Feb 2025, 21:19 UTC

Market Talk

Mexico's Inflation Seen Up in Early February -- Market Talk

21 Feb 2025, 20:15 UTC

Market Talk

Global Equities Roundup: Market Talk

21 Feb 2025, 20:15 UTC

Market Talk

JPMorgan Chase Branch Expansion Portends Deposit Growth -- Market Talk

21 Feb 2025, 20:05 UTC

Market Talk

Oil Futures Retreat Into the Weekend Again -- Market Talk

21 Feb 2025, 19:58 UTC

Market Talk

U.S. Natural Gas Futures Post Third Straight Weekly Gain -- Market Talk

21 Feb 2025, 19:29 UTC

Market Talk

Gold Slides After Finding Record High -- Market Talk

21 Feb 2025, 19:26 UTC

Top News

Major U.S. Stock Indexes Slip; UnitedHealth Pulls Down DJIA -- WSJ

21 Feb 2025, 19:05 UTC

Market Talk

Business Conditions Seen as Favoring Corporate Credit -- Market Talk

21 Feb 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

21 Feb 2025, 19:02 UTC

Market Talk

Corporate Credit Expected to Be Hit Unevenly by Trade Wars -- Market Talk

21 Feb 2025, 19:00 UTC

Market Talk

Long-Term Treasury Yields Expected to Rise -- Market Talk

Peer Comparison

Price change

Gimv NV Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

224 / 545 Finance

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c